Advertisement
CDLX vs HHS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDLX is a Buy and HHS is a Buy.
CDLX's RSI Indicator is sitting in oversold zone for 22 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for CDLX just turned positive on October 23, 2026. Looking at past instances where CDLX's MACD turned positive, the stock continued to rise in 29 of 41 cases over the following month. The odds of a continued upward trend are 71%.
Following a +14.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where CDLX advanced for three days, in 206 of 261 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
CDLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CDLX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for CDLX entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.589) is normal, around the industry mean (-0.838). P/E Ratio (-0.086) is within average values for comparable stocks, (18.118). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.501). Dividend Yield (0.000) settles around the average of (0.078) among similar stocks. P/S Ratio (0.114) is also within normal values, averaging (1.860).
The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. CDLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CDLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.
HHS in +1.78% Uptrend, rising for three consecutive days on October 28, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HHS advanced for three days, in 182 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HHS's RSI Oscillator exited the oversold zone, 20 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 69 cases where HHS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
HHS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HHS as a result. In 75 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
HHS moved below its 50-day moving average on October 20, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HHS crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HHS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for HHS entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.942) is normal, around the industry mean (-1.044). P/E Ratio (-5.195) is within average values for comparable stocks, (17.091). Projected Growth (PEG Ratio) (0.472) is also within normal values, averaging (0.772). Dividend Yield (0.850) settles around the average of (613.760) among similar stocks. P/S Ratio (0.219) is also within normal values, averaging (2.059).
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. HHS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HHS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
CDLX | HHS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 57 | 51 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 14 Undervalued | 35 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 97 | |
PRICE GROWTH RATING 1..100 | 95 | 37 | |
P/E GROWTH RATING 1..100 | 8 | 94 | |
SEASONALITY SCORE 1..100 | 90 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CDLX's Valuation (14) in the Internet Software Or Services industry is in the same range as HHS (35) in the Advertising Or Marketing Services industry. This means that CDLX’s stock grew similarly to HHS’s over the last 12 months.
CDLX's Profit vs Risk Rating (100) in the Internet Software Or Services industry is in the same range as HHS (100) in the Advertising Or Marketing Services industry. This means that CDLX’s stock grew similarly to HHS’s over the last 12 months.
HHS's SMR Rating (97) in the Advertising Or Marketing Services industry is in the same range as CDLX (100) in the Internet Software Or Services industry. This means that HHS’s stock grew similarly to CDLX’s over the last 12 months.
HHS's Price Growth Rating (37) in the Advertising Or Marketing Services industry is somewhat better than the same rating for CDLX (95) in the Internet Software Or Services industry. This means that HHS’s stock grew somewhat faster than CDLX’s over the last 12 months.
CDLX's P/E Growth Rating (8) in the Internet Software Or Services industry is significantly better than the same rating for HHS (94) in the Advertising Or Marketing Services industry. This means that CDLX’s stock grew significantly faster than HHS’s over the last 12 months.
| CDLX | HHS | |
|---|---|---|
| RSI ODDS (%) | 6 days ago 84% | 1 day ago 69% |
| Stochastic ODDS (%) | N/A | 1 day ago 70% |
| Momentum ODDS (%) | N/A | 1 day ago 77% |
| MACD ODDS (%) | 1 day ago 71% | N/A |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 71% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 83% |
| Advances ODDS (%) | 17 days ago 79% | 1 day ago 72% |
| Declines ODDS (%) | 3 days ago 89% | 7 days ago 77% |
| BollingerBands ODDS (%) | 1 day ago 81% | 1 day ago 72% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CDLX’s FA Score shows that 2 FA rating(s) are green while HHS’s FA Score has 0 green FA rating(s).
- CDLX’s FA Score: 2 green, 3 red.
- HHS’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CDLX’s TA Score shows that 4 TA indicator(s) are bullish while HHS’s TA Score has 4 bullish TA indicator(s).
- CDLX’s TA Score: 4 bullish, 2 bearish.
- HHS’s TA Score: 4 bullish, 5 bearish.
Price Growth
CDLX (@Advertising/Marketing Services) experienced а -11.60% price change this week, while HHS (@Industrial Conglomerates) price change was +1.01% for the same time period.
The average weekly price growth across all stocks in the @Advertising/Marketing Services industry was -3.03%. For the same industry, the average monthly price growth was -10.67%, and the average quarterly price growth was -4.13%.
The average weekly price growth across all stocks in the @Industrial Conglomerates industry was +0.94%. For the same industry, the average monthly price growth was -7.28%, and the average quarterly price growth was -13.78%.
Reported Earning Dates
CDLX is expected to report earnings on Nov 05, 2026.
HHS is expected to report earnings on Nov 09, 2026.
Industries' Descriptions
@Advertising/Marketing Services (-3.03% weekly)Making a brand known to people, garnering more clients/consumers for its product and solidifying the brand’s position in an industry – all of these are essential to a company’s growth, and that’s where marketing/advertising come in as one of the key catalysts. Advertising industry is a global multibillion-dollar business of public relations and marketing companies, media services and advertising agencies – entities that help to connect manufacturers/producers with customers. Digital media has played a big role in the growth of global advertising, and agencies invest substantially to integrate advanced technologies into their business operations. According to some estimates, the U.S. advertising industry is expected to generate revenue of $52.6 billion by 2023, up from almost $40 billion in 2015 . Omnicom Group Inc., Trade Desk, Inc. and Interpublic Group of Companies, Inc. are some of the major U.S. companies in the industry.
@Industrial Conglomerates (+0.94% weekly)Industrial Conglomerates specialize in numerous types of products, most of which comprise industrial goods, while some also go towards meeting household needs. Honeywell (makes engineering services and aerospace systems), United Technologies Corporation(manufactures aircraft engines, aerospace systems, HVAC, elevators and escalators, fire and security, building systems, and industrial products, among others), 3M (over 60,000 products under several world-renowned brands, including adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection films, dental and orthodontic products, electrical & electronic connecting and insulating materials, medical products, car-care products, electronic circuits, healthcare software and optical films).
Advertisement
CDLX and
Correlation & Price change
A.I.dvisor tells us that CDLX and STGW have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CDLX and STGW's prices will move in lockstep.
| Ticker / NAME | Correlation To CDLX | 1D Price Change % | ||
|---|---|---|---|---|
| CDLX | 100% | -4.76% | ||
| STGW - CDLX | 30% Poorly correlated | -0.23% | ||
| WIMI - CDLX | 28% Poorly correlated | -0.70% | ||
| BOC - CDLX | 27% Poorly correlated | +0.55% | ||
| DLX - CDLX | 25% Poorly correlated | -0.30% | ||
| HHS - CDLX | 22% Poorly correlated | +1.01% | ||
More | ||||
HHS and
Correlation & Price change
A.I.dvisor tells us that HHS and WPP have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HHS and WPP's prices will move in lockstep.